Article
Bayer claims early lead in Parkinson's stem cell therapy
Rating:
0.0
Views:
55
Likes:
1
Library:
1
Bayer subsidiary BlueRock has become the first company to report initial success treating Parkinson's disease in humans using an experimental stem cell therapy, the drugmaker said on Wednesday.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value